A Call for Vaccine Against COVID-19: Implications for Cardiovascular Morbidity and Healthcare Utilization

Jamie S Y Ho¹, Paul A Tambyah^{2

3}, Ching-Hui Sia^{4

5}

Affiliations

¹ School of Clinical Medicine, University of Cambridge, Cambridge, UK.
² Division of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore, Singapore.
³ Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
⁴ Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. ching_hui_sia@nuhs.edu.sg.
⁵ Department of Cardiology, National University Heart Centre, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore. ching_hui_sia@nuhs.edu.sg.

Jamie S Y Ho et al. Cardiovasc Drugs Ther. 2020 Aug.

. 2020 Aug;34(4):585-587.

doi: 10.1007/s10557-020-06985-z.

Jamie S Y Ho¹, Paul A Tambyah^{2

3}, Ching-Hui Sia^{4

5}

¹ School of Clinical Medicine, University of Cambridge, Cambridge, UK.
² Division of Infectious Diseases, University Medicine Cluster, National University Hospital, Singapore, Singapore.
³ Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
⁴ Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. ching_hui_sia@nuhs.edu.sg.
⁵ Department of Cardiology, National University Heart Centre, 5 Lower Kent Ridge Rd, Singapore, 119074, Singapore. ching_hui_sia@nuhs.edu.sg.

No abstract available

Conflict of interest statement

None.

1. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020. 10.1161/CIRCULATIONAHA.120.046941. - PubMed
1. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 10.1001/jamacardio.2020.1017. - PMC - PubMed
1. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345–353. doi: 10.1056/NEJMoa1702090. - DOI - PubMed
1. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008;29(11):1350–1358. doi: 10.1093/eurheartj/ehm581. - DOI - PubMed
1. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310(16):1711–1720. doi: 10.1001/jama.2013.279206. - DOI - PubMed